Stay updated with breaking news from Genomics Systems. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New chief executive officers take the reins of companies, while chief financial officers step into their roles overseeing the finances of respective businesses and more.
Singular Genomics Systems (NASDAQ:OMIC – Get Rating) is one of 43 public companies in the “Analytical instruments” industry, but how does it weigh in compared to its rivals? We will compare Singular Genomics Systems to related companies based on the strength of its dividends, earnings, profitability, risk, institutional ownership, analyst recommendations and valuation. Earnings & […]
Singular Genomics Systems (NASDAQ:OMIC – Get Rating) is one of 42 public companies in the “Analytical instruments” industry, but how does it contrast to its peers? We will compare Singular Genomics Systems to similar businesses based on the strength of its institutional ownership, valuation, profitability, dividends, earnings, risk and analyst recommendations. Analyst Recommendations This is […]
Singular Genomics Systems (NASDAQ:OMIC – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it compare to its rivals? We will compare Singular Genomics Systems to similar companies based on the strength of its valuation, institutional ownership, profitability, earnings, risk, analyst recommendations and dividends. Profitability This table compares […]
Singular Genomics Systems (NASDAQ:OMIC – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Saturday, Zacks.com reports. The firm currently has a $3.75 price objective on the stock. Zacks Investment Research‘s target price suggests a potential upside of 12.28% from the stock’s […]